Anti-inflammatory effect of thalidomide alone or in combination with augmentin in Klebsiella pneumoniae B5055 induced acute lung infection in BALB/c mice

European Journal of Pharmacology

Volumn 592, Issue 1-3, 2008, Pages 146-150

  Kumar, Vijay ^a   Chhibber, Sanjay ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Augmentin; Inflammation; Klebsiella pneumoniae B5055; Malondialdehyde; Myeloperoxidase; Nitric oxide; Thalidomide

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; THALIDOMIDE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYME ACTIVITY; HISTOPATHOLOGY; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DATA INTERPRETATION, STATISTICAL; IMMUNOSUPPRESSIVE AGENTS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PEROXIDASE; PNEUMONIA, BACTERIAL; THALIDOMIDE;

EID: 49749149492     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.019     Document Type: Article

References (24)

1. Arend W.P., and Dayer J.M. Inhibition of production and effect of IL-1 and TNF-α in rheumatoid arthritis. Arthritis. Rheum. 38 (1995) 151-160
2. Arruda M.S.P., Richini V.B., Oliveria S.M.A., and Villani-Moreno F.R. Experimental murine mycobacteriosis: evaluation of the functional activity of alveolar macrophages in the thalidomide treated mice. Braz. J. Med. Biol. Res. 37 (2004) 485-492
3. Bernard J.W., Biro M.G., Lo S.K., Ohno S., Carozzo M.A., Moyle M., Soul H.R., and Malik A.B. Neutrophil inhibitory factor prevents neutrophil dependent lung injury. J. Immunol. 155 (1995) 4876-4881
4. Faure M., Thivolt J., and Gaucherand M. Inhibition of PMN leukocytes chemotaxis by thalidomide. Arch. Dermatol. Res. 269 (1980) 275-280
5. Geitz H., Handt S., and Zwingenberger K. Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacology 31 (1996) 213-221
6. Greenberger M.J., Strieter R.M., Kunkel S.L., Danforth J.M., Goodman R.E., and Standiford T.J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J. Immunol. 155 (1995) 722-729
7. Hasegawa N., Oka Y., Nakayama M., Berry G.J., Burnsten S., Rice G., and Raffin T.A. The effect of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs. Am. J. Respir. Crit. Care Med. 155 (1997) 928-936
8. Held T.K., Mielke M.E.A., Chedid M., Unger M., Trautman M., Huhn D., and Cross A.S. Granulocyte colony-stimulating factor worsens the outcome of the experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood 91 (1998) 2525-2533
9. Hoffman H., Weiss M., Frank G., Birg A., Schonharting M.M., and Jochum M. Amelioration of endotoxin induced acute lung injury in pigs by HWA 138 and A 80 2715: new analogs of pentoxifylline. Shock 4 (1995) 166-170
10. Jeyaseelan S., Chu H.W., Young S.K., and Warthen G.S. Transcriptional profiling of lipo-polysaccharide induced acute lung injury. Infect. Immun. 72 (2004) 7247-7256
11. Leonard C., and Alans B.F. Thalidomide: current and potential clinical applications. Am. J. Med. 108 (2000) 487-495
12. MacLaren R., and Jung R. Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults. Pharmacotherapy 22 (2002) 1140-1156
13. Miyachi Y. Pharmacologic modulation of neutrophil functions. Clin. Dermatol. 18 (2000) 369-373
14. Miyachi Y., Ozaki M., Uchida K., and Niwa Y. Effect of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes. Arch. Dermatol. Res. 273 (1982) 363-367
15. Moreira A.L., Sampaio E.P., Zmuidzinas A., Frindt P., Smith K.A., and Kaplan G. Thalidomide exerts its inhibitory action on TNF-α by enhancing mRNA degradation. J. Exp. Med. 177 (1993) 1675-1680
16. Ohkawa H., Ohishi N., and Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
17. Schultz M.J., and Poll T.V. Modulation of innate immune responses in the treatment of sepsis and pneumonia. Curr. Drug Targets-Inflamm. Allergy 3 (2004) 11-17
18. Tadesse A., and Shannon E.J. Effect of thalidomide in intracellular Mycobacterium leprae in normal and activated macrophages. Clin. Diag. Lab. Immunol. 12 (2005) 130-134
19. Tamaoki J. The effects of macrolides on inflammatory cells. CHEST 125 (2004) 41S-51S
20. Tasaka S., Hasegawa N., and Ishzika A. Pharmacology of acute lung injury. Pulm. Pharmacol. Ther. 15 (2002) 83-95
21. Tsai W.C., Strieter R.M., Zisman D.A., Wilkowski J.M., Bucknell K.A., Chen G., and Standiford T.J. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect. Immun. 65 (1997) 1870-1875
22. Woo P.C.Y., Lau S.K.P., and Yuen K.-Y. Macrolides as immunomodulatory agents. Curr. Med. Chem. Anti-inflam. Anti-Allerg. Agents 1 (2002) 131-141
23. Yadav V., Sharma S., Harjai K., Mohan H., and Chhibber S. Induction and resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in the mice. Ind. J. Med. Res. 118 (2003) 47-52
24. Yasui K., Kobayashi N., Yamazaki T., and Agematsu K. Thalidomide as an immunotherapeutic agent: the effect on neutrophil mediated inflammation. Curr. Pharma. Des. 11 (2005) 395-401